GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tabula Rasa HealthCare Inc (NAS:TRHC) » Definitions » Beneish M-Score

Tabula Rasa HealthCare (Tabula Rasa HealthCare) Beneish M-Score : -3.41 (As of May. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tabula Rasa HealthCare Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.41 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Tabula Rasa HealthCare's Beneish M-Score or its related term are showing as below:

TRHC' s Beneish M-Score Range Over the Past 10 Years
Min: -4.57   Med: -2.59   Max: -1.66
Current: -3.41

During the past 10 years, the highest Beneish M-Score of Tabula Rasa HealthCare was -1.66. The lowest was -4.57. And the median was -2.59.


Tabula Rasa HealthCare Beneish M-Score Historical Data

The historical data trend for Tabula Rasa HealthCare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tabula Rasa HealthCare Beneish M-Score Chart

Tabula Rasa HealthCare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.88 -2.56 -2.51 -3.51 -4.32

Tabula Rasa HealthCare Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.87 -4.57 -4.32 -4.20 -3.41

Competitive Comparison of Tabula Rasa HealthCare's Beneish M-Score

For the Health Information Services subindustry, Tabula Rasa HealthCare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tabula Rasa HealthCare's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tabula Rasa HealthCare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Tabula Rasa HealthCare's Beneish M-Score falls into.



Tabula Rasa HealthCare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Tabula Rasa HealthCare for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8167+0.528 * 1.0014+0.404 * 1.3355+0.892 * 1.2228+0.115 * 1.1417
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9948+4.679 * -0.225116-0.327 * 1.191
=-3.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Total Receivables was $57.5 Mil.
Revenue was 90.036 + 88.277 + 82.708 + 77.101 = $338.1 Mil.
Gross Profit was 22.529 + 20.753 + 19.692 + 16.866 = $79.8 Mil.
Total Current Assets was $146.7 Mil.
Total Assets was $355.9 Mil.
Property, Plant and Equipment(Net PPE) was $19.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $24.4 Mil.
Selling, General, & Admin. Expense(SGA) was $89.0 Mil.
Total Current Liabilities was $93.7 Mil.
Long-Term Debt & Capital Lease Obligation was $333.4 Mil.
Net Income was -9.851 + -15.898 + -29.642 + -40.065 = $-95.5 Mil.
Non Operating Income was -2.784 + 0.052 + -7.946 + 0.479 = $-10.2 Mil.
Cash Flow from Operations was 5.107 + -8.754 + -2.396 + 0.913 = $-5.1 Mil.
Total Receivables was $57.6 Mil.
Revenue was 72.597 + 67.11 + 68.897 + 67.91 = $276.5 Mil.
Gross Profit was 15.966 + 14.389 + 18.333 + 16.695 = $65.4 Mil.
Total Current Assets was $266.3 Mil.
Total Assets was $484.5 Mil.
Property, Plant and Equipment(Net PPE) was $24.8 Mil.
Depreciation, Depletion and Amortization(DDA) was $43.0 Mil.
Selling, General, & Admin. Expense(SGA) was $73.1 Mil.
Total Current Liabilities was $154.1 Mil.
Long-Term Debt & Capital Lease Obligation was $334.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(57.486 / 338.122) / (57.564 / 276.514)
=0.170016 / 0.208178
=0.8167

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(65.383 / 276.514) / (79.84 / 338.122)
=0.236455 / 0.236128
=1.0014

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (146.681 + 19.518) / 355.937) / (1 - (266.304 + 24.782) / 484.468)
=0.533066 / 0.399164
=1.3355

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=338.122 / 276.514
=1.2228

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(43.024 / (43.024 + 24.782)) / (24.419 / (24.419 + 19.518))
=0.634516 / 0.555773
=1.1417

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(88.977 / 338.122) / (73.145 / 276.514)
=0.263151 / 0.264525
=0.9948

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((333.414 + 93.691) / 355.937) / ((333.997 + 154.128) / 484.468)
=1.199945 / 1.007548
=1.191

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-95.456 - -10.199 - -5.13) / 355.937
=-0.225116

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Tabula Rasa HealthCare has a M-score of -3.41 suggests that the company is unlikely to be a manipulator.


Tabula Rasa HealthCare Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Tabula Rasa HealthCare's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Tabula Rasa HealthCare (Tabula Rasa HealthCare) Business Description

Traded in Other Exchanges
N/A
Address
228 Strawbridge Drive, Suite 100, Moorestown, NJ, USA, 08057
Tabula Rasa HealthCare Inc is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The cloud-based software solutions of the company help prescribers, pharmacists, and healthcare organizations in managing the medication-related needs of patients. The firm operates the business through two segments namely CareVention HealthCare and MedWise HealthCare.
Executives
Michael Anthony Bruno officer: CHIEF ACCOUNTING OFFICER 1504 PEAR TREE LANE, BENSALEM PA 19020
Derek C Schrier director, 10 percent owner C/O INDABA CAPITAL MANAGEMENT, LLC, ONE LETTERMAN DR., BLDING D, SUITE DM700, SAN FRANCISCO CA 94129
Indaba Capital Fund, L.p. director, 10 percent owner MAPLES CORPORATE SERVICES, 121 SOUTH CHURCH STREET, GRAND CAYMAN E9 KY1-1104
Indaba Capital Management, L.p. director, 10 percent owner ONE LETTERMAN DRIVE, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Ic Gp, Llc director, 10 percent owner ONE LETTERMAN DRIVE,, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Rew Richard W. Ii officer: Chief Legal Officer, Secretary 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
Thomas Cancro officer: CHIEF FINANCIAL OFFICER C/O GFI GROUP INC., NEW YORK NY 10041
Michael J. Purcell director C/O PATRIOT NATIONAL, INC., 401 E. LAS OLAS BLVD., SUITE 1650, FORT LAUDERDALE FL 33301
Ronald Paul Mitchell director 110 W. KINZIE STREET, 5TH FL, CHICAGO IL 60654
Jonathan David Schwartz director 430 EAST 29TH STREET, SUITE 1040, NEW YORK NY 10016
Dennis Helling director 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Michael Greenhalgh officer: Chief Operating Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Gordon Tunstall director
Andrea Carolan Speers officer: Chief Accounting Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Brian W Adams officer: Chief Financial Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057